Loxo Oncology to Announce Fourth Quarter and Year-End 2017 Financial Results
February 22 2018 - 6:45AM
Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company
innovating the development of highly selective medicines for
patients with genetically defined cancers, will announce financial
results for the fourth quarter and full year ended December 31,
2017 on March 1, 2018 before the Nasdaq market open. At 8:00 a.m.
ET that day, Loxo Oncology management will host a conference call
to discuss these financial results, in addition to recent updates
on development and corporate activities.
To participate in the conference call, please dial (877)
930-8065 (domestic) or (253) 336-8041 (international) and refer to
conference ID 7395447. A replay will be available shortly after the
conclusion of the call and archived on the company's website for 30
days following the call.
About Loxo OncologyLoxo Oncology is a
biopharmaceutical company innovating the development of highly
selective medicines for patients with genetically defined cancers.
Our pipeline focuses on cancers that are uniquely dependent on
single gene abnormalities, such that a single drug has the
potential to treat the cancer with dramatic effect. We believe that
the most selective, purpose-built medicines have the highest
probability of maximally inhibiting the intended target, thereby
delivering best-in-class disease control and safety. Our management
team seeks out experienced industry partners, world-class
scientific advisors and innovative clinical-regulatory approaches
to deliver new cancer therapies to patients as quickly and
efficiently as possible. For more information, please visit the
company's website at www.loxooncology.com.
Contacts for Loxo Oncology, Inc.
Company: Jacob S. Van Naarden Chief Business
Officerjake@loxooncology.com
Investors:Peter Rahmer The Trout Group, LLC 646-378-2973
prahmer@troutgroup.com
Media:Dan Budwick
1AB Media973-271-6085
dan@1abmedia.com
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Jun 2024 to Jul 2024
LOXO ONCOLOGY, INC. (NASDAQ:LOXO)
Historical Stock Chart
From Jul 2023 to Jul 2024